Group 1 - The core viewpoint of the news highlights the recent performance of Rui Li Medical Beauty, which saw a stock price increase of 9.32% despite a cumulative decline of 6.35% over the past month, while the Hang Seng Index dropped by 1.6% [1][2] - Financial data indicates that Rui Li Medical Beauty achieved total revenue of 199 million yuan, a year-on-year increase of 5.26%, but reported a net loss of 59.21 million yuan, a significant decrease of 82.43% compared to the previous year [2] - The company's gross profit margin stands at 35.82%, with a debt-to-asset ratio of 61.78% [2] Group 2 - Currently, there are no institutional investment ratings for Rui Li Medical Beauty, and its price-to-earnings ratio is -1.03, ranking 101st in the healthcare equipment and services industry, which has an average TTM P/E ratio of -1.13 [3] - The company operates as a leading medical beauty service provider in Zhejiang, China, offering a wide range of services including cosmetic surgery, minimally invasive beauty services, and skin beauty services, along with consulting services for third-party medical beauty institutions [4] - Rui Li Medical Beauty has expanded its service network over 14 years, operating four private profit-making medical beauty service institutions in China, with over 30 practicing physicians averaging more than ten years of industry experience [4]